These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2738415)

  • 1. Detection of IgG4 antibodies by immunoblotting in patients on vespid venom immunotherapy.
    Einarsson R; Inganäs M; Karlsson T; Persson B
    J Immunol Methods; 1989 Jun; 120(2):265-9. PubMed ID: 2738415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of antibodies in patients on immunotherapy with insect venoms by immunoblotting.
    Einarsson R
    Int Arch Allergy Appl Immunol; 1987; 83(2):217-9. PubMed ID: 3294603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergens in Hymenoptera venom XV: The immunologic basis of vespid venom cross-reactivity.
    Hoffman DR
    J Allergy Clin Immunol; 1985 May; 75(5):611-3. PubMed ID: 2580878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE, IgG, IgG1 and IgG4 patterns in yellow jacket allergic patients during immunotherapy with a venom depot extract.
    Jeep S; Meysel U; Kunkel G
    Clin Exp Allergy; 1992 Feb; 22(2):297-302. PubMed ID: 1571821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
    Gentlesk MJ; Halpern GM; Mansmann HC
    Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
    Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergens in Hymenoptera venom. XVI: Studies of the structures and cross-reactivities of vespid venom phospholipases.
    Hoffman DR
    J Allergy Clin Immunol; 1986 Aug; 78(2):337-43. PubMed ID: 3734285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A1-based cross-reactivity among venoms of clinically relevant Hymenoptera from Neotropical and temperate regions.
    Perez-Riverol A; Fernandes LGR; Musacchio Lasa A; Dos Santos-Pinto JRA; Moitinho Abram D; Izuka Moraes GH; Jabs F; Miehe M; Seismman H; Palma MS; de Lima Zollner R; Spillner E; Brochetto-Braga MR
    Mol Immunol; 2018 Jan; 93():87-93. PubMed ID: 29156294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.
    Monsalve RI; Vega A; Marqués L; Miranda A; Fernández J; Soriano V; Cruz S; Domínguez-Noche C; Sánchez-Morillas L; Armisen-Gil M; Guspí R; Barber D
    Allergy; 2012 Apr; 67(4):528-36. PubMed ID: 22229815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical studies of yellowjacket venom proteins.
    King TP; Alagon AC; Kuan J; Sobotka AK; Lichtenstein LM
    Mol Immunol; 1983 Mar; 20(3):297-308. PubMed ID: 6865952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vespid venoms collected by electrostimulation and by venom sac extraction.
    Mueller U; Reisman R; Wypych J; Elliott W; Steger R; Walsh S; Arbesman C
    J Allergy Clin Immunol; 1981 Oct; 68(4):254-61. PubMed ID: 7288046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergens in Hymenoptera venom XIV: IgE binding activities of venom proteins from three species of vespids.
    Hoffman DR
    J Allergy Clin Immunol; 1985 May; 75(5):606-10. PubMed ID: 3989146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets.
    King TP; Joslyn A; Kochoumian L
    J Allergy Clin Immunol; 1985 May; 75(5):621-8. PubMed ID: 3989148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
    Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow jacket venom allergens, hyaluronidase and phospholipase: sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy.
    King TP; Lu G; Gonzalez M; Qian N; Soldatova L
    J Allergy Clin Immunol; 1996 Sep; 98(3):588-600. PubMed ID: 8828537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W; Chyrek-Borowska S
    Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of prolonged venom immunotherapy in children.
    Graft DF; Schuberth KC; Kagey-Sobotka A; Kwiterovich KA; Niv Y; Lichtenstein LM; Valentine MD
    J Allergy Clin Immunol; 1987 Aug; 80(2):162-9. PubMed ID: 3611537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.